Mammaglobin is a protein that is typically found in breast tissue, and more specifically in breast cancer cells. The immunohistochemistry (IHC) test for mammaglobin, or IHC - Mammaglobin, is a diagnostic procedure used primarily to detect and diagnose breast cancer. It can also help determine the origin of metastatic tumors that may have spread from the breast to other parts of the body.
IHC - Mammaglobin is an important tool in the pathologist's arsenal for the confirmation of breast origin in metastatic cases, where the primary site is unknown. By staining the cancer cells for the presence of mammaglobin, pathologists can determine whether the cells originated in the breast.
The IHC - Mammaglobin test involves staining a tissue sample with an antibody that binds to mammaglobin. The presence of this protein indicates that the tissue is from the breast.
The IHC - Mammaglobin test helps to confirm the diagnosis of breast cancer and can also help determine the origin of metastatic tumors. This can guide treatment decisions and provide important prognostic information.
No specific preparation is needed for the IHC - Mammaglobin test. You should follow any instructions provided by your doctor.
The IHC - Mammaglobin test is usually ordered when a diagnosis of breast cancer is suspected or when the origin of a metastatic tumor is unknown.
The frequency of testing is determined by your doctor based on your individual health condition and the course of your disease.
The presence of mammaglobin in tissue samples is considered abnormal, as this protein is typically found in breast cancer cells.
There are no specific precautions needed before or after the IHC - Mammaglobin test.
Levels of mammaglobin can be influenced by the presence of breast cancer or metastatic tumors that originated in the breast.
The presence of mammaglobin in a tissue sample is usually indicative of breast cancer or a metastatic tumor that originated in the breast.
If your test results are abnormal, you should consult an oncologist or a breast cancer specialist.
No, fasting is not required for the IHC - Mammaglobin test.
This test provides information about the presence of mammaglobin, a protein found in breast cancer cells, which can help confirm a diagnosis of breast cancer or determine the origin of a metastatic tumor.
No, this test cannot be done at home. It requires a tissue sample, which must be collected and analyzed in a laboratory.
Non-modifiable factors include genetics and age, as breast cancer risk increases with age and can be influenced by genetic predispositions. Modifiable factors could include lifestyle changes, as maintaining a healthy diet and regular physical activity can help reduce the risk of breast cancer.
The test itself is not painful. However, obtaining the tissue sample for testing may involve a biopsy, which can cause discomfort or pain.